1
Return

Evaluation of CGRP Levels in Patients With Rosacea: A Prospective Case–Control Study

delete2026-06-27
delete0
delete
OA
AI
E
Esranur Ünal *
V
Veysel Duru
S
Selma Emre
M
Muhammed Burak Yücel
S
Serpil Erdoğan
S
Sinem Örnek
DOI:10.1155/dth/3024577delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Calcitonin gene–related peptide (CGRP) is a vasoactive neuropeptide implicated in the neurovascular dysregulation and neurogenic inflammation involved in rosacea pathogenesis. However, evidence regarding circulating CGRP levels in rosacea remains limited. Therefore, this study aimed to compare serum CGRP levels between patients with rosacea and healthy controls and to investigate their associations with rosacea severity, subtype, and Demodex positivity.
Keywords:
calcitonin gene–related peptide
Demodex
neurogenic inflammation
neurovascular dysregulation
rosacea
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Dermatologic Therapy cover
Dermatologic Therapy
IF:
3.4
Papers:
4.8K
Citations:
7.1K

Organization

M
memorial kayseri hospital
Scholars:
2
Papers: 1
Citations: 0
B
bilkent city hospital
Scholars:
57
Papers: 30
Citations: 0
U
ufuk university
Scholars:
67
Papers: 41
Citations: 0
G
Guy's and St Thomas' NHS Foundation Trust
Scholars:
511
Papers: 259
Citations: 35
Cited Papers

Cited Papers

Citing Papers

Citing Papers